Posted:
4/29/2026, 9:54:20 AM
Location(s):
Metro Manila, Philippines ⋅ New York, United States ⋅ Manila, Metro Manila, Philippines ⋅ City of Albany, New York, United States
Experience Level(s):
Senior
Field(s):
Medical, Clinical & Veterinary
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected]. If you have questions while submitting an application, please review these frequently asked questions.
Current Employees and Students:
If you are currently employed or enrolled as a student at The Ohio State University, please log in to Workday to use the internal application process.
Welcome to The Ohio State University's career site. We invite you to apply to positions of interest. In order to ensure your application is complete, you must complete the following:
Ensure you have all necessary documents available when starting the application process. You can review the additional job description section on postings for documents that may be required.
Prior to submitting your application, please review and update (if necessary) the information in your candidate profile as it will transfer to your application.
The Research Senior Associate will assist and support the center for antibody therapeutics (CAT) at the Pelotonia Institute for Immuno-Oncology (PIIO) under direct supervision of Dr. Zhiwei Hu, Managing Director of the PIIO CAT at the OSUCCC – James. Research Senior Associate will participate in planning, executing, and analyzing translational cancer research with focus on antibodies/proteins, antibody drug conjugates, bispecific antibodies, antibody-based CAR-NK and CAR-T cell immunotherapy using advanced molecular, cellular and antibody-based techniques.
The OSUCCC – James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nation’s largest public universities.
Pelotonia Institute for Immuno-Oncology (PIIO) is a comprehensive bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at all levels - from prevention to treatment and survivorship.
The Center for Antibody Therapeutics (CAT) at the PIIO is a specialized technology hub dedicated to the discovery, development, production, optimization, and translation of antibody-based therapeutics from basic science research to preclinical and clinical studies for cancer treatment. The Center will leverage cutting-edge technologies to develop monoclonal antibodies, bispecific antibodies (bsAb), antibody-drug conjugates (ADCs), antibody engineering, and other antibody-based immunotherapies including CAR-T and CAR-NK cells. This center will serve the PIIO research community, clinical teams, and external partners by providing essential expertise and infrastructure to accelerate immuno-oncology research from basic science discovery to translational research, commercialization towards clinical trials in alignment with the overall strategic growth goals of the PIIO.
Final candidates are subject to successful completion of a background check. A drug screen or physical may be required during the post offer process.
Thank you for your interest in positions at The Ohio State University and Wexner Medical Center. Once you have applied, the most updated information on the status of your application can be found by visiting the Candidate Home section of this site. Please view your submitted applications by logging in and reviewing your status. For answers to additional questions please review the frequently asked questions.
The university is an equal opportunity employer, including veterans and disability.
Website: https://www.osu.edu/
Headquarter Location: Wooster, Ohio, United States
Year Founded: 1870
IPO Status: Private
Industries: Agriculture ⋅ Education ⋅ Higher Education